The question whether the gain-of-function mutations driving CYP11B2 autonomy are the same as cause the adenomas has not been settled, and there may indeed be a fine balance between cell growth and death depending on the mutation and/or expression level of the mutated channel (81, 82). This evidence concerns the gene CYP11B2 and adenoma.